Physician profile
Ray B Terrell
NPI 1447257415
$1,406.63
in general payments reported to CMS, 2019-2025
23 companies · $211 in 2025
The $211 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246 · 2020: $356 · 2021: $62.63 · 2022: $271 · 2023: $114 · 2024: $146 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $471.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $528.00 | 2019-2025 | Xtandi, Myrbetriq |
| Axonics, INC. | $140.22 | 2020-2024 | Axonics, Bulkamid |
| Medtronic, INC. | $121.37 | 2022-2025 | Altaviva |
| Boston Scientific Corporation | $97.87 | 2019-2025 | Moses 550 Dfl, Axonics |
| Calyxo, INC. | $75.16 | 2025 | Cvac Aspiration System |
| Janssen Biotech, INC. | $69.35 | 2019-2023 | Erleada |
| Halozyme INC | $66.86 | 2023 | |
| Urovant Sciences INC | $41.88 | 2022 | |
| Endo Pharmaceuticals INC. | $28.27 | 2020 | |
| Tempus Ai, INC | $27.71 | 2024 | |
| Teleflex LLC | $20.75 | 2025 | Barrigel |
| Sumitomo Pharma America, INC. | $20.67 | 2023 | Orgovyx |
| Agiliti Surgical, INC. | $20.09 | 2025 | Koelis Trinity Mri/US Fusion |
| Abbvie INC. | $19.86 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $19.76 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $18.49 | 2019 | |
| Myriad Genetic Laboratories, INC. | $18.08 | 2022 | |
| Urogen Pharma, INC. | $14.64 | 2025 | |
| Neotract INC. | $13.10 | 2019 | |
| Medtronic USA, INC. | $11.41 | 2019 | |
| Pfizer INC. | $11.05 | 2020 | |
| Sagent Pharmaceuticals | $11.02 | 2020 | |
| Antares Pharma, INC. | $11.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ray Terrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.